Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials

INTRODUCTION: Patients with atopic dermatitis (AD) have high disease burden negatively affecting quality of life. AIM: To assess the efficacy and safety of dupilumab in patients with moderate-to-severe AD. MATERIAL AND METHODS: A systematic literature search was performed using the main-stream datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuying, Wang, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326918/
https://www.ncbi.nlm.nih.gov/pubmed/35950124
http://dx.doi.org/10.5114/ada.2022.117740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326918/
https://www.ncbi.nlm.nih.gov/pubmed/35950124
http://dx.doi.org/10.5114/ada.2022.117740

Ejemplares similares